soul study semaglutide The Oral Semaglutide Significantly Improves Cardiovascular

Case reports cannot prove causation

2024;10(3):e756

Expected Results (According to Clinical Trials) Retatrutide has generated significant scientific interest due to its robust efficacy signals in early clinical trials: Weight reduction: Clinical data have shown that patients receiving higher titration doses experienced substantial weight loss, in some cases exceeding 20% of baseline body weight over extended treatment periods

Additional warnings include risk of pancreatitis, gallbladder disease, and diabetic retinopathy complications (with semaglutide)

For many, these digestive improvements contribute as much to quality of life as the weight management benefits